Login
0
₹ 0
What is BILYPSA 4MG?
- BILYPSA 4MG contains Saroglitazar which is a dual regulator that corrects both the lipid profile and the glycemic indices
CONSUMER MEDICINE INFORMATION
THERAPEUTIC USES
WARNING & PRECAUTIONS
INTERACTIONS
DIRECTIONS FOR USE
SIDE EFFECTS
MORE INFORMATION
What BILYPSA 4MG is used for?
It is indicated for the treatment of,
- diabetic dyslipidemias
- reduction of triglycerides (TG), Low Density Lipoprotein (LDL) cholesterol, Very Low-Density Lipoprotein (VLDL) cholesterol, and an increase in HDL cholesterol. It has also shown favorable glycemic indices by reducing the fasting plasma glucose and glycosylated haemoglobin in diabetic patients
Talk to your doctor before taking this medicine, if you:
- are allergic to saroglitazar or any other ingredients of its medicine
- have abnormal liver function
- have kidney problems
- have history of myopathy
- have cardiac disease
- The safety of saroglitazar in pregnant women and breast feeding has not been established as there is no adequate and well controlled study carried out in pregnant women
- Women who become pregnant, breast feeding during saroglitazar treatment should contact their physicians
- Always take this medicine as per your doctors advice
- The recommended dose of Saroglitazar is one tablet of 4 mg once a day
- Swallow this tablet whole with a glass of water
If you take more of Saroglitazar
- If you take more of Saroglitazar, contact your doctor immediately
If you forgot to take Saroglitazar
- Take it as soon as possible. Do not double the dose
If you stop take Saroglitazar
- Do not stop taking without your doctors advice
Disclaimer:
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.
